MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia

MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia

Prostate cancer (PCa) is the most commonly diagnosed neoplasm among men. Since it often resembles benign prostate hyperplasia (BPH), biomarkers with a higher differential value than PSA are required. Epigenetic biomarkers in liquid biopsies, especially miRNA, could address this challenge. The absolu...

Full description

Bibliographic Details
Main Authors: Irena Abramovic, Borna Vrhovec, Lucija Skara, Alen Vrtaric, Nora Nikolac Gabaj, Tomislav Kulis, Goran Stimac, Dejan Ljiljak, Boris Ruzic, Zeljko Kastelan, Bozo Kruslin, Floriana Bulic-Jakus, Monika Ulamec, Ana Katusic-Bojanac, Nino Sincic
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
prostate cancer
microRNA
liquid biopsy
biomarkers
benign prostate hyperplasia
plasma
Online Access:https://www.mdpi.com/2072-6694/13/9/2068

Internet

https://www.mdpi.com/2072-6694/13/9/2068

Similar Items